Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | 7,800 | reported | 02 Jan 2026 | tx 17+9,129,740.01−148,109.75 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 2,600 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 7,800 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 2,600 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 7,800 | 0.00 USD | deriv |
| 11 Oct 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 1,518,373 | — | |
| 11 Oct 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 45,551.19 | — | deriv |
| 08 Apr 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 491,853 | — | |
| 08 Apr 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 2,926,764 | — | |
| 08 Apr 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 14,755.61 | — | deriv |
| 08 Apr 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 87,802.95 | — | deriv |
| 02 Jan 2024 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 178,000 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 228,000 | 0.00 USD | deriv |
| 13 Nov 2023 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 257,739 | 0.00 USD | |
| 13 Nov 2023 | OTHER | Cartesian Therapeutics, Inc. | 3,303,699 | 0.00 USD | |
| 13 Nov 2023 | PURCHASE | Cartesian Therapeutics, Inc. | 619.63 | 249999.98 USD | deriv |
| 13 Nov 2023 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 14,755.61 | — | deriv |
| 13 Nov 2023 | OTHER | Cartesian Therapeutics, Inc. | 189,136.77 | — | deriv |